本篇回應
vanillam 認為 含有個人意見
引用自 vanillam 查核回應
新聞內引述來自bioRxiv網站一份以56人作研究的報告,網站及報告開首已提醒,他們刊載的「報告」並未經正式審閱,不能在媒體中用作結論。
bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

不同意見出處

https://www.biorxiv.org/content/10.1101/2021.09.30.462488v1

https://www.cdc.gov.tw/Category/QAPage/xvN5xl0uGdBq6joYoe3LZw

Durability of immune responses to the BNT162b2 mRNA vaccine

The development of the highly efficacious mRNA vaccines in less than a year since the emergence of SARS-CoV-2 represents a landmark in vaccinology. However, reports of waning vaccine efficacy, coupled

https://www.biorxiv.org/content/10.1101/2021.09.30.462488v1

以上內容「Cofacts 真的假的」訊息回報機器人與查證協作社群提供,以 CC授權 姓名標示-相同方式分享 4.0 (CC BY-SA 4.0) 釋出,於後續重製或散布時,原社群顯名及每一則查證的出處連結皆必須被完整引用。